Novartis Institutes
2
45M
2
0.11
1
1
- Areas of investment
Summary
Novartis Institutes appeared to be the Corporate Investor, which was created in 2002. The main department of described Corporate Investor is located in the Cambridge. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Novartis Institutes, startups are often financed by MPM Capital, OUP (Osage University Partners), 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Pfizer Venture Investments, OUP (Osage University Partners). In the next rounds fund is usually obtained by WuXi Healthcare Ventures, Roche Venture Fund, Perceptive Advisors.
Among the most popular portfolio startups of the fund, we may highlight Blade Therapeutics, IDEAYA Biosciences. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 1 and less years to get the investment from the fund.
The increased amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.11
- Investments by industry
- Health Care (2)
- Therapeutics (2)
- Biotechnology (1)
- Biopharma (1)
- Pharmaceutical (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| IDEAYA Biosciences | 03 May 2016 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 46M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.